We Are Ballbusting Success

With the happening of approval and pendency of launch we are ballbusting already. Our #1 CEO in Biotechnology Ron has opened a door that will be creating a success like no other. This is the year when Acorda doing the needful with bring the sales that my batchmates and I were born to deliver. Tell the Junglee that his negativity cannot take away from our progress and approval.

 

Habib, lay off the sauce and take a deep breath. Wait until you actually launch and see revenue before you blow your RonWad.

#1 CEOs aren’t at the bottom of a five year stock price going into a launch. BTw, there is nothing biotech about a 505b2 company.

 

Junglee do not tell us now that you are on a visa. You make the racist antiimmigrant comments daily from your mothers basement. Acorda is biotech from the start and forever. You should find a new job and make your nasty comments there.

 

Acorda was a BioTech when Tony Cagiano was the Head of Development and Dr Blight big Boss. Those two really knew how to move fascinating science. Dr Blank is not quite there yet.

 

is inhaled LD the only thing ACOR has been able to cook up in the past nine years? WTH is going on over there? (Overheard at JPM).

 

Company confidentiality policies are very very strict. As such, we who post on CP cannot disclose this info. But there are many ballbusters being cooked up in the pipeline ! Our Leader is on top of the situation.

 

We are improving motor function like no other. The doctors are exciting the Inbrija ballbusting with knowing that the motor is on when the patient is off. This is like no other and write now driving the uptake for the launch. Lancet is the most premiere journal and the prestige can lift our spirits and our sales. Let the ballbusting begin.

 

You have to actually be available for prescription first Habib.

 

We are excitement with launch ticking down. ARCUS platform is springing us to new heights beyond the negatives. Are you knowing acute migraine for another ball buster ? Many of the global Pharma want to have this but our ARCUS makes this are own. Such an excitement time to be an Acordian !

 

YES !!! WE ARE DOING GREAT !!!!!!! GREAT LEADERSHIP BEGETS GREAT RESULTS !!!!

 

up over 1% already today !!!!!!!

 

UP 1.3% FRIDAY, NOW OVER $15 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

LET THE PARTY BEGIN !!!!!!!!!!!!!!!!

THANK YOU RON AND DR BLANK !!!!!!!!!!!!!

 

Awesome. Now let's see if we can get to $ 35 by the end of the year.
That will be quite an accomplishment

For that, everyone needs to execute to perfection.
Plus "Mr." Blank needs to GROW the pipeline. (Good luck with that one, though)

Caggiano & Blight, come saves us.

 

AND DON'T FORGET THE MEXICANS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

AUGOSTO COME SAVE US !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

 

*************
Mr Caggiano is long gone and not part of the future plans. Nothing further to add about other name. We must support our great r&d team headed by the highly regarded Dr. Blank. Making it to $35 by end of year is doable but all hands must be selling Inbrija to the max. That means ALL of rank&file must dig in and work harder. Let's GO GO GO !!
*************

 

Did Blank switch positions and now is in Sales ?

I thought his job was the pipeline.

You got to build that pipeline, and soon. What is there now is not enough to build a company

Perhaps the best course of action is a M&A with Teva.

 

Anyone that left this place NEVER came back, When you look back, it sucked. Poor decisions made. One trick pony. Heard the offers to buy Inbrija and disintegrate the company are swooping in.

 

Last post is just negative for no reason

This is a good company with an awesome product.
Sure, M&A is not a bad option.
BUT whichever company wants it, better be prepared to make a generous offer for Acorda.
Given the Cash-at-hand, no less than $ 25.

In the meantime, let's ALL give our 150% for Inbrija and make its Launch be triple-good compare to Ampyra.

 

*************
There will be no m & a path forward. Period. We have a strong pipeline of winners being introduced soon. ACOR will hit mid 30's this year if all do their job and sell to the physicians! It's on your back! Get to work!
*************

 

Guessing that "Mr" Blank must have concocted some new compounds over the weekend.

Di*khead, you been saying that same crap for over two years, the pipeline has just gotten smaller and smaller.

There is no pipeline.

M&A is a valid path forward.